Bajaj Finserv Healthcare Fund Direct Growth

Bajaj Finserv Healthcare Fund Direct Growth

NAV as on 17-04-2025

₹ 9.26

▲0.6%

1D

Inception Returns

-7.4%

/yr

Historical NAV & Returns

Absolute

zero opening, trading, fund transfer fee
536 people have invested ₹ 11.3L in Bajaj Finserv Healthcare Fund Direct Growth in the last three months

About Bajaj Finserv Healthcare Fund Direct Growth

Bajaj Finserv Healthcare Fund Direct Growth is an equity fund. This fund was started on 27 December, 2024. The fund is managed by Sorbh Gupta, Siddharth Chaudhary. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Bajaj Finserv Healthcare Fund Direct Growth has ₹307 Cr worth of assets under management (AUM) as on Mar 2025 and is less than category average.
  2. The fund has an expense ratio 0.6.

Returns

Bajaj Finserv Healthcare Fund Direct Growth has given a CAGR return of -7.41% since inception.

Holdings

Bajaj Finserv Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Consumer Defensive, Basic Materials. Its top holdings are Divi's Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Dr Reddy's Laboratories Ltd, Cipla Ltd, Apollo Hospitals Enterprise Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of Bajaj Finserv Healthcare Fund Direct Growth

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 500.00 and for SIP is INR 500.00. Bajaj Finserv Healthcare Fund Direct Growth has no lock in period.

Bajaj Finserv Healthcare Fund Direct Growth Overview

Expense ratio0.61%
Benchmark
BSE Healthcare TR INR
AUM₹307 Cr
Inception Date27 December, 2024
Min Lumpsum/SIP₹500/₹500
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
0%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

Trailing Returns

as on (17-Apr-25)

Period
Bajaj Finserv Healthcare Fund Direct Growth
Nifty 500
sector - healthcare
1M
5%
6.9%
4.2%
3M
-4.2%
0%
-3.1%

Fund Distribution

as on (31-Mar-25)

  • Equity 92.1%

  • Debt & Cash 8%

Large cap
37.7%

Mid cap
27%

Small cap
26.4%

Sector Allocation

Mar'25

Feb'25

Jan'25

Health
91%
Consumer Defensive
8%
Basic Materials
1%
  • Returns %

  • Fund Ratios

  • Overview

Funds
1Y Returns
3Y Returns
5Y Returns
Since Inception
Bajaj Finserv Healthcare Fund Direct Growth
Bajaj Finserv Healthcare Fund Direct Growth
-
-
-
-7.41%
UTI Healthcare Fund-Growth Option- Direct
UTI Healthcare Fund-Growth Option- Direct
22.13%
20.25%
23.63%
16.18%
SBI Healthcare Opportunities Fund Direct Growth
SBI Healthcare Opportunities Fund Direct Growth
21.64%
23.93%
26.46%
18.24%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
21.02%
23.46%
26.57%
22.41%
  • Gainers

  • Losers

Top Growth Drivers
1M Return
Piramal Pharma Ltd
Piramal Pharma Ltd
7.7%
Fund
Mar'25
Feb'25
Jan'25
No of Holdings
39
38
38
Top 5 Company Concentration
38.6%
39.1%
38.3%
Company having highest exposure
Divi's Laboratories Ltd (8.9%)
Divi's Laboratories Ltd (9.2%)
Divi's Laboratories Ltd (8.7%)
No of Sectors
3
3
3
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (91%)
Health (90.6%)
Health (91.6%)
Loading...
We are taking more time than usual
Sorbh Gupta
Sorbh Gupta
Fund Manager of Bajaj Finserv Healthcare Fund Direct Growth, since 27 December 2024
Siddharth Chaudhary
Siddharth Chaudhary
Fund Manager of Bajaj Finserv Healthcare Fund Direct Growth, since 27 December 2024
Fund House
Bajaj Finserv Asset Management Limited
Total AUM
₹19.59K Cr
as on 31-Mar-2025
Address
India
Phone
+912071576064
Website

Bajaj Finserv Healthcare Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
Fund Allocations

Fund Allocations

This fund has an allocation of 92.05% in Equity, 0% in Debt and 7.95% in Cash related instruments
AUM size ₹307 Cr

AUM size ₹307 Cr

This fund has AUM of ₹307 Cr which is less than its category average of ₹ 1821 Cr
Expense Ratio 0.61%

Expense Ratio 0.61%

This fund has an expense ratio of 0.61% which is less than its category average expense ratio of 1.44%

Frequently Asked Questions for Bajaj Finserv Healthcare Fund Direct Growth

The current NAV of Bajaj Finserv Healthcare Fund Direct Growth is ₹9.26 as on 17-Apr-2025.
Existing (Absolute + CAGR) as on 17-Apr-2025.
Bajaj Finserv Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
4.97%
4.97%
6 Month Returns
0%
0%
1 Year Returns
0%
0%
3 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.61% as on March 2025
₹307 Cr as on March 2025
Divi's Laboratories Ltd(8.88%), Sun Pharmaceuticals Industries Ltd(8.44%), Dr Reddy's Laboratories Ltd(7.9%), Cipla Ltd(7.82%), Apollo Hospitals Enterprise Ltd(5.51%) as on March 2025
Health(83.76%), Consumer Defensive(7.33%), Basic Materials(0.96%) as on March 2025
The alpha ratio for the Bajaj Finserv Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Bajaj Finserv Healthcare Fund Direct Growth
-
-
-
As on March 2025
The alpha for Bajaj Finserv Healthcare Fund Direct Growth is calculated against BSE Healthcare TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Bajaj Finserv Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Bajaj Finserv Healthcare Fund Direct Growth
-
-
-
As on March 2025
The Beta for Bajaj Finserv Healthcare Fund Direct Growth is calculated with BSE Healthcare TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Bajaj Finserv Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Bajaj Finserv Healthcare Fund Direct Growth
-
-
-
As on March 2025
The sharpe ratio for Bajaj Finserv Healthcare Fund Direct Growth is calculated with BSE Healthcare TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Bajaj Finserv Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Bajaj Finserv Healthcare Fund Direct Growth
-
-
-
As on March 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sorbh Gupta, Siddharth Chaudhary are the fund managers of Bajaj Finserv Healthcare Fund Direct Growth
The Exit load of Bajaj Finserv Healthcare Fund Direct Growth is 1%